BackgroundCheck.run
Search For

Sun P Hong, 56Phoenix, AZ

Known as:
Sun Pyo Hong Sun Living Hong Pyo Hong Sun Su Hong Seung Hong Pyo Hung Sun Pyo Hong Sun
Related to:
Young Sook Hong 72

Sun Hong Phones & Addresses

Phoenix, AZ   

Schiller Park, IL   

Bloomington, IL   

1824 Dunhill Cir, Glenview, IL 60025    847-6120325   

Chicago, IL   

Skokie, IL   

Perrysburg, OH   

Toledo, OH   

Get Report
Control this profile

Mentions for Sun P Hong

Sun Hong resumes & CV records

Resumes

Sun Hong Photo 43

Sun Hee Hong

Sun Hong Photo 44

Sales Manager

Work:
Genera Corp Auto Part
Sales Manager
Sun Hong Photo 45

Sun Min Hong

Sun Hong Photo 46

Sun Hong

Location:
United States

Publications & IP owners

Us Patents

Molecular Response And Progression Detection From Circulating Cell Free Dna

US Patent:
2022036, Nov 17, 2022
Filed:
Jul 7, 2022
Appl. No.:
17/859599
Inventors:
- Chicago IL, US
Christine Lo - Chicago IL, US
Jonathan Alexander Heiss - Chicago IL, US
Robert Tell - Chicago IL, US
Sun Hae Hong - Belmont CA, US
International Classification:
G16B 40/00
G16B 20/20
G16B 5/20
G06F 30/27
Abstract:
Methods, systems, and software are provided for monitoring a cancer condition of a test subject. The method includes obtaining a liquid biopsy sample from the subject at a second time point, occurring after a first time point, containing cell-free DNA fragments. Low-pass whole genome methylation sequencing of the cell-free DNA fragments is performed to obtain nucleic acid sequences having a methylation pattern for a corresponding cell-free DNA fragment. The nucleic acid sequences are mapped to a location on a reference genome. Methylation metrics are determined based on the methylation patterns and mapped locations of the nucleic acid sequences. A circulating tumor fraction is estimated from the methylation metrics, and the estimate is compared to an estimate of the circulating tumor fraction for the test subject at the first time point.

Molecular Response And Progression Detection From Circulating Cell Free Dna

US Patent:
2021039, Dec 23, 2021
Filed:
Jun 18, 2021
Appl. No.:
17/352231
Inventors:
- Chicago IL, US
Christine Lo - Chicago IL, US
Jonathan Alexander Heiss - Chicago IL, US
Robert Tell - Chicago IL, US
Sun Hae Hong - Belmont CA, US
International Classification:
G16B 40/00
G16B 20/20
G16B 5/20
G06F 30/27
Abstract:
Methods, systems, and software are provided for monitoring a cancer condition of a test subject. The method includes obtaining a liquid biopsy sample from the subject at a second time point, occurring after a first time point, containing cell-free DNA fragments. Low-pass whole genome methylation sequencing of the cell-free DNA fragments is performed to obtain nucleic acid sequences having a methylation pattern for a corresponding cell-free DNA fragment. The nucleic acid sequences are mapped to a location on a reference genome. Methylation metrics are determined based on the methylation patterns and mapped locations of the nucleic acid sequences. A circulating tumor fraction is estimated from the methylation metrics, and the estimate is compared to an estimate of the circulating tumor fraction for the test subject at the first time point.

Possible Relatives

Cynthia M Hong  David C Hong  Dawn Y Hong  Deanna Hong  Deborah H Hong  Daniel S Hong  Denise C Hong  Sun J White  Sun Y Jones  Sun K Jung 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.